Cargando…

Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection

Detalles Bibliográficos
Autores principales:	Steels, Sophie, Van Elslande, Jan, De Munter, Paul, Bossuyt, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926884/ https://www.ncbi.nlm.nih.gov/pubmed/35296990 http://dx.doi.org/10.1007/s10875-022-01235-3

Ejemplares similares

IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
por: Decru, Bram, et al.
Publicado: (2022)

Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers
por: Decru, Bram, et al.
Publicado: (2022)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response
por: Lin, Yi-Chun, et al.
Publicado: (2020)

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
por: Kannan, Saathvik R., et al.
Publicado: (2022)

IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination
por: Van Elslande, Jan, et al.
Publicado: (2022)

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
por: Ortega, Natalia, et al.
Publicado: (2021)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia
por: Lee, Eun-Ju, et al.
Publicado: (2021)

SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?
por: Voulalas, Grigorios, et al.
Publicado: (2021)

Complementarity determining regions in SARS-CoV-2 hybrid immunity
por: Frans, Glynis, et al.
Publicado: (2023)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective
por: La Sala, Lucia, et al.
Publicado: (2020)

Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Pre-Existing Microbiome Signature in a SARS-CoV-2 Discordant Family
por: Hazan, Sabine
Publicado: (2022)

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
por: Lin, Chun-Yang, et al.
Publicado: (2022)

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
por: Van Elslande, Jan, et al.
Publicado: (2022)

Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
por: Mantus, Grace, et al.
Publicado: (2022)

On the concentration of SARS-CoV-2 in outdoor air and the interaction with pre-existing atmospheric particles
por: Belosi, Franco, et al.
Publicado: (2021)

Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals
por: Taira, Naoyuki, et al.
Publicado: (2022)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2020)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination
por: Amraotkar, Alok R., et al.
Publicado: (2022)

The Effects of SARS-CoV-2 Infection on the Cognitive Functioning of Patients with Pre-Existing Dementia
por: Dubey, Souvik, et al.
Publicado: (2023)

Existence of SARS-Cov-2 in the Peritoneal Fluid
por: Ilgen, Orkun, et al.
Publicado: (2023)

SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
por: Ward, Victoria, et al.
Publicado: (2022)

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
por: Van Elslande, Jan, et al.
Publicado: (2021)

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
por: Nantambi, Hellen, et al.
Publicado: (2023)

Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases
por: Nayak, Baibaswata, et al.
Publicado: (2021)

Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection
por: Garbo, Riccardo, et al.
Publicado: (2022)

SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
por: Verma, Henu Kumar, et al.
Publicado: (2021)

Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
por: Anft, Moritz, et al.
Publicado: (2021)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)

Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)

Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes
por: Islam, M. Babul, et al.
Publicado: (2021)

Comparative analysis between STANDARD‐E Covi‐FERON ELISA with pre‐existing IFN‐γ release assays and determination of the optimum cutoff value for assessment of T‐Cell response to SARS‐CoV‐2
por: Jang, Jieun, et al.
Publicado: (2023)

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
por: Imbrechts, Maya, et al.
Publicado: (2022)

Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies
por: Jentzer, Alexandre, et al.
Publicado: (2022)

Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response
por: Atef, Shereen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mtiloaked683em7mn5gnosctd8